Patent Term Extension Application for ENFLONSIA (clesrovimab-cfor) Patent No. 9,963,500

Documents

Comments

Key Dates

Comment Period OpensSep 10, 2025

Comment Period ClosesJun 3, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA FR Doc: 2026-06479	Apr 3, 2026	--

CDER

Merck Sharp and Dohme LLC

Covington and Burling LLP

Patent Term Extension Application

for ENFLONSIA clesrovimab cfor

Patent No 9963500

OPEN